Test Code LAB23 Digoxin Level
Clinical System Name
Digoxin Level
Synonyms
LAB23
DIG
Lanoxin
Sample Requirements
Specimen: Whole Blood
Container(s): Gold SST, Gold Microtainer, Red
Preferred Vol: 1.0 mL
Minimum Vol: 0.5 mL
Note: Draw specimen immediately before next dose (within 30 minutes). Avoid hemolysis. A hemoglobin level of 300 mG/dl causes a bias of -0.6. Test is also affected if patient is hypertensive, uremic, or a neonate. There is some cross-reactivity to Digoxin-Like Immunoreactive Factors (DLIF). Digibind affects method. Method is not affected by moderate lipemia.
Processing Instructions
Reject due to: Age of specimen, incorrect collection container.
Spin: Y
Aliquot: Y
Storage location: Core Chemistry Refrigerator
Off-site collection: Draw specimen immediately before next dose (within 30 minutes). Avoid hemolysis. Specimen should be centrifuged within 2 hours of collection. Spin blood and transfer serum to plastic tube and refrigerate or freeze.
Stability
Specimen Type | Temperature | Time |
---|---|---|
Serum | RT |
≤ 8 h |
Serum | 2-8 C |
≤ 7 d |
Serum | -20 C or -70 C |
≤ 4 m |
Availability
STAT | Performed | TAT |
---|---|---|
Y | 24/7 | 1 h |
Performing Laboratory
Seattle Children's Laboratory
Department
Department: Core Chemistry
Phone Number: 206-987-2617 (Client Services)
CPT Codes
80162
Methodology
Method: Multiple Point Immuno-Rate method by Vitros 4600
Analytical Volume: 0.02 mL + 0.03 mL dead space
Method is affected by EDTA & hemolysis.
Reference Range
0.5 - 2.0 ng/mL
Description
Digoxin is a widely prescribed cardiac glycoside indicated in the treatment of congestive heart failure and supraventricular arrhythmias. Digoxin measurements are used to monitor patient compliance and therapy, and to diagnose potential overdose.
Critical Values
> 2.5 ng/mL